Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

T6654

Ticlopidine hydrochloride

analytical standard, for drug analysis

Synonym(s):

5-(o-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
1 g
Check Cart for Availability
$42.30

About This Item

Empirical Formula (Hill Notation):
C14H14ClNS · HCl
CAS Number:
53885-35-1
Molecular Weight:
300.25
NACRES:
NA.24
PubChem Substance ID:
329826850
UNSPSC Code:
41116107
EC Number:
258-837-4
MDL number:
MFCD00079606

$42.30

Check Cart for Availability
​
Request a Bulk Order
​
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Segment

100

assay

≥99%

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

application(s)

forensics and toxicology
pharmaceutical (small molecule)
veterinary

format

neat

SMILES string

Cl.Clc1ccccc1CN2CCc3sccc3C2

InChI

1S/C14H14ClNS.ClH/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14;/h1-4,6,8H,5,7,9-10H2;1H

InChI key

MTKNGOHFNXIVOS-UHFFFAOYSA-N

Gene Information

human ... P2RY12(64805)

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
Ticlopidine hydrochloride has been used as an analytical standard to investigate the developmental toxicity and teratogenic potential of ticlopidine in Xenopus laevis embryos and human endothelial cells using a frog embryo teratogenesis assay-Xenopus (FETAX) and blood and lymph vessel formation assay.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
B5274M187PHR3367
Ticlopidine hydrochloride analytical standard, for drug analysis

Supelco

T6654

Ticlopidine hydrochloride

Bupivacaine hydrochloride monohydrate analytical standard, for drug analysis

Supelco

B5274

Bupivacaine hydrochloride monohydrate

(+)-3-Methoxymorphinan hydrochloride analytical standard, for drug analysis

Supelco

M187

(+)-3-Methoxymorphinan hydrochloride

Ticlopidine hydrochloride certified reference material, pharmaceutical secondary standard

Supelco

PHR3367

Ticlopidine hydrochloride

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

technique(s)

-

format

neat

format

neat

format

neat

format

-

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

300

assay

≥99%

assay

≥99%

assay

-

assay

-

Gene Information

human ... P2RY12(64805)

Gene Information

-

Gene Information

-

Gene Information

-

application(s)

forensics and toxicology
pharmaceutical (small molecule)
veterinary

application(s)

forensics and toxicology
pharmaceutical (small molecule)
veterinary

application(s)

forensics and toxicology
pharmaceutical (small molecule)
veterinary

application(s)

pharmaceutical small molecule

Still not finding the right product?

Explore all of our products under Ticlopidine hydrochloride

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H302

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCK6162
BCCF8044
BCCF4027
BCCC6457
BCBZ4684

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Characterization of ticlopidine-induced developmental and teratogenic defects in Xenopus embryos and human endothelial cells.
Park SM, et al.
Chemico-Biological Interactions, 240, 172-178 (2015)
Jan H Cornel et al.
American heart journal, 168(1), 76-87 (2014-06-24)
To further explore the impact of smoking on antiplatelet activity and treatment response, we evaluated time-dependent relationships between smoking status with on-treatment platelet reactivity and clinical outcomes for prasugrel vs. clopidogrel in patients with acute coronary syndromes managed medically without
Stephen D Wiviott et al.
Lancet (London, England), 382(9892), 605-613 (2013-08-21)
Treatment with prasugrel and aspirin improves outcomes compared with clopidogrel and aspirin for patients with acute coronary syndrome who have had angiography and percutaneous coronary intervention; however, no clear benefit has been shown for patients managed first with drugs only.
View All Related Papers

Global Trade Item Number

SKUGTIN
T6654-1G04061837371820
T6654-5G04061833654095
T6654-25G04061833654088

Questions

Reviews

No rating value

Active Filters